Human medicines European public assessment report (EPAR): Toujeo (previously Optisulin), insulin glargine, Date of authorisation: 26/06/2000, Revision: 36, Status: Authorised

Submitted by Anonymous (not verified) on 2 September 2024 - 14:45

Human medicines European public assessment report (EPAR): Toujeo (previously Optisulin), insulin glargine, Date of authorisation: 26/06/2000, Revision: 36, Status: Authorised

Human medicines European public assessment report (EPAR): Toujeo (previously Optisulin), insulin glargine, Date of authorisation: 26/06/2000, Revision: 36, Status: Authorised

Submitted by Anonymous (not verified) on 2 September 2024 - 14:45

Human medicines European public assessment report (EPAR): Toujeo (previously Optisulin), insulin glargine, Date of authorisation: 26/06/2000, Revision: 36, Status: Authorised

Human medicines European public assessment report (EPAR): Saphnelo, anifrolumab, Date of authorisation: 14/02/2022, Revision: 7, Status: Authorised

Submitted by Anonymous (not verified) on 30 August 2024 - 14:40

Human medicines European public assessment report (EPAR): Saphnelo, anifrolumab, Date of authorisation: 14/02/2022, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Azacitidine Kabi, azacitidine, Date of authorisation: 05/01/2024, Revision: 1, Status: Authorised

Submitted by Anonymous (not verified) on 30 August 2024 - 14:29

Human medicines European public assessment report (EPAR): Azacitidine Kabi, azacitidine, Date of authorisation: 05/01/2024, Revision: 1, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More